Park, Shi-Young <br/><br/>
Ethyl pyruvate, an anti-inflammatory agent, inhibits tumor angiogenesis through inhibition of the NF-κB signaling pathway.  [electronic resource] 

 -  Cancer letters  Apr 2011 
 - 150-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2010.12.024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Anti-Inflammatory Agents--pharmacology<br/>Carcinoma, Lewis Lung--metabolism<br/>Cell Line, Tumor<br/>Cell Movement<br/>Collagen--chemistry<br/>Drug Combinations<br/>Endothelial Cells--cytology<br/>Humans<br/>Laminin--chemistry<br/>Mice<br/>Mice, Inbred C57BL<br/>NF-kappa B--metabolism<br/>Neovascularization, Pathologic<br/>Proteoglycans--chemistry<br/>Pyruvates--pharmacology<br/>Signal Transduction<br/>Vascular Endothelial Growth Factor A--metabolism<br/>Wound Healing